Coya Therapeutics Cash Flow Statement (2022-2025) | COYA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Depreciation and Depletion 0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation 0.02M0.04M0.07M0.07M0.18M0.19M0.26M0.24M0.44M0.66M0.78M0.79M1.08M1.04M1.07M
Gains from Investment Securities 0.48M0.02M1.13M1.24M1.13M0.01M2.20M2.23M0.08M2.96M3.02M
Non-cash Items 0.27M0.34M1.90M0.47M0.44M0.54M6.90M6.20M5.40M1.29M7.10M1.67M
Cash from Operations -1.98M-1.44M-1.59M-2.22M-3.86M-2.87M-2.22M-2.24M2.15M-4.56M-5.46M-2.41M-2.83M-5.77M-1.13M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables -0.37M0.77M0.05M0.39M-0.27M-0.30M0.40M0.48M0.48M0.24M-1.49M1.25M0.10M-0.76M0.18M
Change in Accured Expenses -0.13M0.17M0.69M0.10M-1.28M0.26M0.19M1.71M-0.84M-1.04M0.41M-0.02M0.42M1.03M-1.20M
Other Working Capital Changes -0.19M-0.01M-0.07M1.20M-0.24M0.28M-0.35M1.81M0.28M1.97M1.14M1.52M-3.13M0.83M0.22M
Investing Activities
Cash from Investing Activities -0.39M-0.19M-0.03M
Financing Activities
Other financing activities 0.01M
Cash from Financing Activities -0.07M9.54M-0.01M-0.10M14.25M24.17M1.24M5.15M-0.06M9.69M0.02M0.02M
Additional items
Change in Cash -2.05M8.10M-1.74M-2.72M10.39M-3.22M-2.22M21.74M3.36M0.59M-5.52M7.28M-2.81M-5.77M-1.63M
Free Cash Flow -1.98M-1.44M-1.59M-2.22M-3.86M-2.87M-2.22M-2.24M2.15M-4.56M-5.46M-2.41M-2.83M-5.77M-1.13M
Net Cash Flow -2.05M8.10M-1.60M-2.72M10.39M-2.87M-2.22M21.74M3.36M0.59M-5.52M7.28M-2.81M-5.77M-1.11M